JP2013505290A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013505290A5 JP2013505290A5 JP2012530363A JP2012530363A JP2013505290A5 JP 2013505290 A5 JP2013505290 A5 JP 2013505290A5 JP 2012530363 A JP2012530363 A JP 2012530363A JP 2012530363 A JP2012530363 A JP 2012530363A JP 2013505290 A5 JP2013505290 A5 JP 2013505290A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dihydropyrrolo
- pyrazol
- oxy
- piperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24506909P | 2009-09-23 | 2009-09-23 | |
| US61/245,069 | 2009-09-23 | ||
| PCT/IB2010/053347 WO2011036576A1 (en) | 2009-09-23 | 2010-07-22 | Gpr 119 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013505290A JP2013505290A (ja) | 2013-02-14 |
| JP2013505290A5 true JP2013505290A5 (enExample) | 2013-07-25 |
Family
ID=42799871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012530363A Withdrawn JP2013505290A (ja) | 2009-09-23 | 2010-07-22 | Ｇｐｒ１１９調節因子 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130072427A1 (enExample) |
| EP (1) | EP2480551A1 (enExample) |
| JP (1) | JP2013505290A (enExample) |
| CA (1) | CA2772188A1 (enExample) |
| WO (1) | WO2011036576A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014011926A1 (en) | 2012-07-11 | 2014-01-16 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| EP2718279B1 (en) | 2011-06-09 | 2016-08-10 | Rhizen Pharmaceuticals SA | Novel compounds as modulators of gpr-119 |
| EP2780026B1 (en) | 2011-11-15 | 2019-10-23 | Merck Sharp & Dohme Corp. | Hcv ns3 protease inhibitors |
| WO2014081718A1 (en) | 2012-11-20 | 2014-05-30 | Genentech, Inc. | Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants |
| CA3085353A1 (en) | 2017-12-21 | 2019-06-27 | Ribon Therapeutics Inc. | Quinazolinones as parp14 inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3839694A1 (de) | 1988-11-24 | 1990-05-31 | Ats Leichtmetallraeder Gmbh | Faltschachtel zur verpackung eines stossempfindlichen produkts, insbesondere einer leichtmetallfelge |
| ES1011809Y (es) | 1989-10-23 | 1991-08-01 | Minano Iglesias Jesus | Muneco-envase. |
| IL157253A0 (en) | 2001-02-28 | 2004-02-19 | Merck & Co Inc | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| UA84208C2 (en) | 2004-05-25 | 2008-09-25 | Пфайзер Продактс Инк. | Tetraazabenzo(e)azulene derivatives and analogs thereof |
| PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
| US7750034B2 (en) * | 2006-01-25 | 2010-07-06 | Merck Sharp & Dohme Corp. | Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| TW200806669A (en) * | 2006-03-28 | 2008-02-01 | Merck & Co Inc | Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| WO2008137436A1 (en) * | 2007-05-04 | 2008-11-13 | Bristol-Myers Squibb Company | [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| CA2693169C (en) | 2007-07-19 | 2016-01-12 | Metabolex, Inc. | N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| JP5009736B2 (ja) | 2007-10-15 | 2012-08-22 | 日本曹達株式会社 | 環状アミノエーテルを用いたマンニッヒ反応 |
| JP2013511571A (ja) * | 2009-11-23 | 2013-04-04 | ファイザー・インク | Ｇｐｒ１１９阻害剤としてのイミダゾ−ピラゾール |
-
2010
- 2010-07-22 CA CA2772188A patent/CA2772188A1/en not_active Abandoned
- 2010-07-22 WO PCT/IB2010/053347 patent/WO2011036576A1/en not_active Ceased
- 2010-07-22 EP EP10747074A patent/EP2480551A1/en not_active Withdrawn
- 2010-07-22 US US13/392,935 patent/US20130072427A1/en not_active Abandoned
- 2010-07-22 JP JP2012530363A patent/JP2013505290A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012526096A5 (enExample) | ||
| JP2012528847A5 (enExample) | ||
| JP2025072577A (ja) | Ｇｌｐ－１ｒアゴニスト及びその使用 | |
| US8895583B2 (en) | Soluble guanylate cyclase activators | |
| US9926314B2 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| JP2013505290A5 (enExample) | ||
| JP6662846B2 (ja) | ６，７−ジヒドロピラゾロ［１，５−ａ］ピラジン−４（５Ｈ）−オン化合物およびＭＧＬＵＲ２受容体の負のアロステリック調節因子としてのそれらの使用 | |
| AU2004289638B2 (en) | Substituted naphthyridinone derivatives | |
| US9233961B2 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| US10596175B2 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| TW201111381A (en) | Pharmaceutical combinations useful for treating HCV | |
| TWI749042B (zh) | 作為飢餓素o-醯基轉移酶(goat)抑制劑的㗁二唑吡啶衍生物 | |
| CA2961531A1 (en) | Sgc stimulators | |
| CN119255988A (zh) | 杂环glp-1激动剂 | |
| KR20160033749A (ko) | 신규한 아자벤즈이미다졸 유도체 | |
| US20170298055A1 (en) | sGC STIMULATORS | |
| TWI873290B (zh) | 作為血漿激肽釋放酶抑制劑之雜芳族甲醯胺衍生物 | |
| JP2024505711A (ja) | 窒素含有多環式縮合環系化合物、その医薬組成物、製造方法及び用途 | |
| EP3615545B1 (en) | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication | |
| JPWO2013002365A1 (ja) | 止痒剤 | |
| TW202400163A (zh) | 使用ｂｃｌ－２抑制劑治療髓性惡性腫瘤之方法 | |
| US20230149393A1 (en) | Inhibitors of trpc6 for treating respiratory conditions | |
| WO2015066252A1 (en) | Glucagon receptor antagonist compounds, compositions thereof, and methods of use | |
| TWI570116B (zh) | 取代的吡唑酮化合物及其使用方法 | |
| KR102904955B1 (ko) | Glp-1r 작용제 및 그의 용도 |